INTRODUCTION
Indirect methods rely on the principle of X chromosome inactivation, which is unique in mammals. Most genes in diploid organisms are expressed from both alleles. However, a subset may be transcribed preferentially from a single allele. Sex chromosome gene dosage equivalence between XY males and XX women was the first described example of an epigenetic process and monoallelic expression 1 . X-chromosome inactivation is a process by which one of the two X chromosomes (or more accurately, most of the genes on that X chromosome) in each cell is inactivated during early female embryonic development. The subsequent progeny of each cell maintains the same inactivated X chromosome pattern resulting in a normal female that is a mosaic of cells; all the coexisting cells will have either a paternally or maternally derived active X chromosome.
Consequently, establishing clonality requires identification of X-chromosome polymorphisms. Detection of human polymorphic X-chromosome genes, subjected to inactivation, was first described by Beutler and colleagues 1 , and was based on electrophoretic distinction of G6PD isoenzyme products in African women. The application of G6PD isoenzyme expression for detection of clonality was first reported in myomas by Gartler and Linder 2 , and then for malignant tumors by Beutler and For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From alleles bearing synonymous, or non-coding, single nucleotide polymorphisms ( Figure 1); i.e. transcriptional clonality assays 5, 6 .
The Lyon-Beutler hypothesis of random X chromosome inactivation provided the basis for assessing hierarchy and clonality of hematopoiesis 1, [7] [8] [9] . According to this hypothesis, the ratio of cells with inactive maternal to paternal X-chromosome should follow a
Poisson distribution with a mean around 0.5. The caveat, though, is that the number of pluripotent stem cells present at the time of inactivation is small [10] [11] [12] . Hence, based on statistical probability, a skewed ratio between cells with either inactive maternal or paternal X-chromosome will be noted in some women. Skewed X-inactivation patterns may occur as a result of a primary stochastic process, or because of secondary cell selection in women heterozygous for certain X-linked genetic diseases 13, 14 . Examples of imbalanced gene expression include random monoallelic (occurring on either autosome or sex chromosome, first foreseen in 1963 15 and recently found to be more wide-spread than previously thought 16 ) and imprinting reviewed in 17 . In mice, genetically determined imbalance of X-chromosome gene expression based on differences of the X-chromosome inactivation locus Xci 18 has been demonstrated; however, a recent study in humans, found this phenomenon to be infrequent since it was not detected in over 500 healthy female mother-neonate pairs 19 .
Extreme skewing of X-chromosome allelic usage by methylation-based clonality assay has been reported in ~30% of healthy elderly women [20] [21] [22] [23] , and has been attributed to the development of clonality and oligoclonality as a consequence of hematopoietic stem cell senescence. Thus, it was recommended that the X-chromosome based clonality assays preclude their use in elderly women [20] [21] [22] [23] . In contrast, employing a quantitative transcriptionally based clonality assay, we have previously established that significant skewing of the ratios of X-chromosome transcribed alleles is a common occurrence in normal healthy women based on our studies demonstrating that 8 progenitors of pluripotent hematopoietic stem cells are present at the time of random X-chromosome inactivation in the female embryo 10 . The conclusion that 8 progenitors of pluripotent hematopoietic stem cells are present at the time of embryonic random X chromosome inactivation was corroborated by others using a different approach 11, 12 . The probability that 7 out of 8 progenitors of pluripotent hematopoietic stem cells would inactivate the only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From same X-chromosome during embryonic development, resulting in a skewed allelic ratio of 7:1 and pseudoclonality, is 0.0078 10 . Based on this observation and those of others 11, 12 , extreme skewing of X-chromosome allelic usage (allele frequency greater than 80%)
is regarded as indicator of clonality. While we previously reported preferential allelic usage of one of the X-chromosomes (selection) in women heterozygous for certain Xlinked diseases 13 
MATERIALS AND METHODS
Study Subjects. This study included four groups of prospectively recruited subjects: 1) healthy elderly woman (>65 years of age) -these subjects did not have any active medical problems, were carefully screened for a history of anemia, autoimmune diseases, and malignant disorders; 2) younger healthy woman (<40 years of age) -age control group for the elderly subjects; 3) women with clonal myeloproliferative disorders -these subjects had well characterized myeloproliferative disorders as per World Health Organization criteria 25 and included polycythemia vera, essential thrombocytosis, and primary myelofibrosis; these served as positive (disease) control for our novel clonality assay; 4) women with non-clonal blood disorders (included secondary thrombocytosis and leukocytosis: these subjects were used as negative controls for our novel clonality assay.
After signing informed consent according to the Declaration of Helsinki, 5 mL of peripheral blood were obtained by venipuncture. Granulocyte, platelet and mononuclear cell fractions were isolated by Histopaque (1.077 g/mL) density gradient based on published protocols 9 . This study received institutional review board approval from the University of Utah. City, CA, USA); 300nM allele-specific, and universal gene-specific primers (Table S1); 125 nM FAM labeled gene-specific MGBNFQ probe (Applied Biosystems, Foster City CA) (Table S1 ); and first strand cDNA. Allele-specific primers were designed using the software program Oligo 6.7 (Molecular Biology Insights, Inc., Cascade, CO, USA).
Phenotypic determination of HCI ratios by HUMARA-methylation assay. HUMARA
assays were performed as previously described 19 . Briefly, DNA after digestion with RsaI and HpaII (digested samples) or without RsaI and HpaII (undigested samples) was amplified using two primers (Table S1) For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From expressed exonic SNPs was calculated as described by Nussenzveig, et. al. 24 . Briefly, the difference in Cycle threshold (ΔC t ) between the two allele-specific PCR reactions is a measure of the proportion or frequency of the expressed allele assuming an initial replication efficiency of 100%. If the amplification efficiencies of the two allele-specific reactions differ slightly, this can be corrected by measuring the ΔC t on a DNA sample known to be heterozygous for the mutation of interest. The ΔC t in the heterozygous sample should be zero, any deviation from zero can be subtracted from all ΔC t measurements in order to compensate for differing amplification efficiencies and is represented by HC (heterozygote correction factor). Therefore, HCΔC t represents the heterozygote corrected difference in cycle threshold between the two allele-specific PCR reactions, and are computed as described in equations 1-3.
and
Results obtained in equations 1 and 2 are used to find the frequency of allele 1 in equation 3:
where E represents the efficiency of PCR amplification for allele 1 and can be deduced by the slope of serially diluted sample.
The ratio of the active/inactive X-chromosome assessed by HUMARA assay was determined as described by Bolduc, et.al. 19 . Briefly, the direction of methylation skewing was determined based on the resulting frequency of allele-A 2 (harbors the greatest number of CAG repeats). 
only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Statistical analysis. The data for the analysis was arranged by pairing of the most predominant allele between markers within a cell lineage (individuals informative for more than one marker), and by pairing of the most predominant allele of identical markers and between cell lineages. All statistics were generated using SAS ® software, Table 1 ). All 45 women were genotyped to determine zygosity of the five X-chromosome exonic polymorphisms (Table   1) . Forty-two women were informative for one or more tested markers (Table 1) . Three women (GC18, GC23 and GC36) were homozygous (non-informative) for all tested Xchromosome polymorphic genes ( Table 1 ). The overall heterozygosity of the polymorphic X-chromosome genes was determined to be 46%, 46%, 19%, 30% and 5%, for FHL1, IDS, MPP1, BTK, and G6PD, respectively; these data are in agreement with previously reported studies using large ethnically diverse populations 10, [26] [27] [28] [29] [30] [31] .
Determination of allele-specific primer specificity, and sensitivity. The difference in ΔC t between the two allele-specific PCR reactions is used to estimate allele frequency, assuming initial amplification efficiency is 100%. The mathematical formulas used to calculate allele frequencies have been reported elsewhere 24, 32 . In these calculations, the initial 2-fold/cycle is used as a value of 100% amplification efficiency. Therefore, it can be inferred that the ΔC t between allele specific reactions reflects fold difference in allele frequencies. Since initial PCR amplification proceeds at a 2-fold geometric rate, then the fold difference between allele frequencies can be estimated by calculating 2 ΔCt . In order to determine the specificity and quantitative sensitivity of the allele-specific primers, total RNA from platelets of homozygous women was isolated with the intention of ascertaining only.
For
the ΔCt values for the two possible genotypes known for each one of the markers. The discrimination of the X-chromosome allelic usage ratio exceeded ΔCt greater than 13 cycles (Table S2) for all X-chromosome polymorphisms used.
Allelic expression ratios of the 5 X-chromosome exonic SNPs in elderly women. Clonality assay for informative markers was performed using RNA from freshly isolated platelets and granulocytes. Based on published data using the HUMARA assay in elderly women we expected to find 12 out of 40 elderly women to have skewed allelic usage. Neither clonal X-chromosome monoallelic expression, nor extreme skewing was noted in any of the study subjects (Table 2) . Moreover, in all of the individuals examined, the Xchromosome allelic expression ratio of the 5 markers tested was <75% of the predominant allele, well within the limits of variation that was established in previous studies (Table   2) 10-12 . Spearman's correlation coefficients were calculated to assess the linear relationship between two markers in platelets or granulocytes, or for the same marker between platelet and granulocyte lineages. Statistically significant correlations were observed, with P<0.0001, for analysis of two different markers and a single hematopoietic lineage ( Figure   2A and B), as well as, for analysis of a single marker on two different hematopoietic lineages ( Figure 2C ). Moreover, general linear models were calculated to test the effects of lineage, marker, and age on allele frequency. Models assessing interaction effects were also computed. Follow-up analysis was performed considering a categorical divide in age between those under 40 years old and those aged 65 or greater. Results of these models comparing our elderly and young cohorts of healthy women are presented in Table 3 .
Comparison between methylation-based HUMARA assay and our novel quantitative clonality assay in elderly women. Based on reported HUMARA data, ~30% elderly women were found to have skewed X-chromosome allelic usage (most prevalent allele frequency greater than 80%). We performed clonality testing by HUMARA assay in all those elderly subjects whenever sufficient genomic DNA was available (30 out of 40 elderly women).
One out of 30 could not be determined due to overlapped PCR stutter peaks; 3 were noninformative (homozygous) based on results from HpaII undigested DNA; 9 had skewed (>80%) HUMARA-based X-chromosome allelic usage; and the remaining 17 elderly women had normal HUMARA-based X-chromosome allelic usage (Table 3) . Presence of only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From skewed allelic methylation ratios in 9/26 (35%) informative elderly women by this assay in our cohort is in agreement with previously reported literature. In contrast, as reported above, we did not observe skewed or clonal hematopoiesis in any of these same individuals using our novel quantitative transcriptional clonality assay. Formal statistical analysis, using an exact binomial test, further emphasized the discrepancy between results obtained using our novel transcriptional clonality assay and analysis of methylation at the HUMARA locus (P<0.0001, exact 95% CI [0,0.1]).
Validation of quantitative clonality assay in patients with clonal hematologic disorders.
We obtained genomic DNA from peripheral blood granulocytes of 15 women with well characterized myeloproliferative disorders and known somatic mutation markers (table 4) .
Out of these 15 women, 8 patients had polycythemia vera, 4 had essential thrombocythemia, 1 had primary myelofibrosis, and 2 had primary myelofibrosis in transformation to acute myeloid leukemia. In addition, 7 women with non-clonal hematological disorders were tested: secondary thrombocytosis (2 patients), secondary erythrocytosis (4 patients), and secondary leukocytosis (1 patient). Using our novel quantitative transcriptional clonality assay, all patients with a myeloproliferative disorder were clonal, while none of the patients with secondary conditions were clonal (Table 4) .
DISCUSSION
Detection of clonality based on discrimination of the state of DNA methylation 4 greatly extended the applicability of X-chromosome inactivation studies to a broader population.
The initial assays for assessment of clonality using X-chromosome inactivation principle were hampered by relatively low allelic frequencies of polymorphic markers used [3] [4] [5] [6] 33 .
However, this shortcoming was overcome by the description of the highly polymorphic CAG repeat in the human androgen-receptor gene (HUMARA assay) which also correlated with X-chromosome inactivation 34 rendering the vast majority of women informative for Age-dependent skewing in the ratio of allelic methylation at the X-chromosome linked HUMARA locus has been reported previously [20] [21] [22] [23] . Likewise, analysis of our cohort of elderly women, using the methylation-based HUMARA assay, is consistent with agedependent skewing at this locus, and preferential methylation of one allele. unanswered, and will have to be addressed in future studies.
In order to address the issue of possible clonal evolution of hematopoiesis with aging, it was necessary to accurately quantify expressed X-chromosome allelic ratios without introducing a bias resulting in preferential detection of one of the polymorphic alleles.
Previously, we used a quantitative and reproducible transcriptional clonality assay based on the ligase detection 6, 10, 31 . However, this method required use of large quantities of radio-labeled nucleotide with high specific-activity. Further, ligated products had to be separated on a polyacrylamide gel, and radioactive bands accurately enumerated by use of a PhosphoImager (Molecular Dynamics. Sunnyvale, CA). This laborious and hazardous method was subsequently replaced by a simpler, semi-quantitative single stranded conformational polymorphism method (SSCP) 26 . Since some X-chromosome genes are only partially or not at all inactivated 41 , we had to prove that all the genes we studied here are subject to X-chromosome inactivation and are polymorphic in all major US ethnic groups, and this was indeed previously documented for the analyses of X-chromosome exonic polymorphisms used here; i.e. We show that all informative elderly women (Table 2 ) exhibit similar ratio of transcribed X-chromosome allelic usage compared to younger women. In addition, both groups of healthy elderly and young women differ by a single statistically significant variable, age.
Finally, our data demonstrate that in the absence of co-morbid conditions, most healthy individuals do not exhibit clonality and oligoclonality of hematopoiesis with ageing.
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For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From Table 2 . X-chromosome exonic polymorphism genotypes and their transcribed allelic frequencies in informative healthy women (37 out of 40 elderly women, coded as GC; and in 4 out of 5 young women, coded as YC) from platelets and granulocytes (normal range for allelic frequencies: 21-80%, determined from >200 healthy women). Hence, women are a mosaic of paternal or maternal active X-chromosome (Step 1).
Inactive X-chromosome is represented by filled red circles. For the transcriptional clonality assay, a specific exonic polymorphism is selected and genotyped (Step 2a).
Allele-specific expression is determined by real-time PCR using reverse-transcribed mRNA as described in materials and methods (Step 3a and 4a). Resulting amplification curve is used to estimate the ∆Ct and corresponding frequencies of each allele (Step 5a).
In contrast, analysis at the HUMARA locus, shown methlyated in the promoter region by filled red circles (Step 2b), is initiated by restriction digestion (scissors) of genomic DNA using a methylation sensitive endonuclease (Step 3b). Following restriction digestion, PCR amplification with primers flanking both the 5'restriction digestion site and the 3' end of the CAG tandem repeat sequence is performed (Step 4b). Hence, only intact, methylated, inactive X-chromosome DNA is amplified. Allele-specific PCR products can be distinguished from each other based on the number of tandem CAG repeats using agarose gel electrophoresis (Step 5b). For personal use
